Rathbones Group PLC Reduces Stock Position in HCA Healthcare, Inc. $HCA

Rathbones Group PLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 12.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 39,771 shares of the company’s stock after selling 5,532 shares during the quarter. Rathbones Group PLC’s holdings in HCA Healthcare were worth $18,567,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Sovran Advisors LLC increased its holdings in shares of HCA Healthcare by 1.0% in the 3rd quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock valued at $1,063,000 after acquiring an additional 22 shares during the last quarter. Centerpoint Advisors LLC increased its holdings in shares of HCA Healthcare by 11.0% in the 3rd quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock valued at $95,000 after acquiring an additional 22 shares during the last quarter. Cary Street Partners Financial LLC increased its holdings in shares of HCA Healthcare by 3.9% in the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock valued at $251,000 after acquiring an additional 22 shares during the last quarter. Plato Investment Management Ltd increased its holdings in shares of HCA Healthcare by 0.6% in the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after acquiring an additional 22 shares during the last quarter. Finally, Angeles Wealth Management LLC increased its holdings in shares of HCA Healthcare by 2.4% in the 3rd quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock valued at $432,000 after acquiring an additional 24 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HCA has been the subject of a number of research analyst reports. KeyCorp lowered their price target on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Sanford C. Bernstein lowered their price objective on HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a research note on Tuesday, April 28th. Robert W. Baird lowered their price objective on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. TD Cowen lowered their price objective on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, April 27th. Finally, Argus lowered their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $515.77.

Read Our Latest Stock Report on HCA

HCA Healthcare Stock Down 1.1%

Shares of HCA Healthcare stock opened at $392.39 on Friday. The firm has a market cap of $87.05 billion, a price-to-earnings ratio of 13.49, a price-to-earnings-growth ratio of 1.26 and a beta of 1.18. The business has a fifty day simple moving average of $468.01 and a 200-day simple moving average of $484.24. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter last year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is currently 10.73%.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.